- Home
- BWFG vs NMRA Comparison
BWFG vs NMRA Comparison
Compare BWFG & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- NMRA
- Stock Information
- Founded
- BWFG 2002
- NMRA 2019
- Country
- BWFG United States
- NMRA United States
- Employees
- BWFG N/A
- NMRA N/A
- Industry
- BWFG Major Banks
- NMRA
- Sector
- BWFG Finance
- NMRA
- Exchange
- BWFG Nasdaq
- NMRA Nasdaq
- Market Cap
- BWFG 333.1M
- NMRA 268.5M
- IPO Year
- BWFG N/A
- NMRA 2023
- Fundamental
- Price
- BWFG $45.95
- NMRA $1.57
- Analyst Decision
- BWFG Buy
- NMRA Hold
- Analyst Count
- BWFG 2
- NMRA 8
- Target Price
- BWFG $42.00
- NMRA $5.83
- AVG Volume (30 Days)
- BWFG 42.4K
- NMRA 376.3K
- Earning Date
- BWFG 10-27-2025
- NMRA 11-11-2025
- Dividend Yield
- BWFG 1.75%
- NMRA N/A
- EPS Growth
- BWFG N/A
- NMRA N/A
- EPS
- BWFG 2.64
- NMRA N/A
- Revenue
- BWFG $81,749,000.00
- NMRA N/A
- Revenue This Year
- BWFG $66.56
- NMRA N/A
- Revenue Next Year
- BWFG $14.45
- NMRA N/A
- P/E Ratio
- BWFG $17.31
- NMRA N/A
- Revenue Growth
- BWFG 0.32
- NMRA N/A
- 52 Week Low
- BWFG $26.39
- NMRA $0.61
- 52 Week High
- BWFG $46.63
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- BWFG 72.30
- NMRA 46.94
- Support Level
- BWFG $44.03
- NMRA $1.42
- Resistance Level
- BWFG $46.63
- NMRA $1.59
- Average True Range (ATR)
- BWFG 1.06
- NMRA 0.10
- MACD
- BWFG 0.11
- NMRA -0.03
- Stochastic Oscillator
- BWFG 86.61
- NMRA 36.14
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.